Extendicare (TSE:EXE – Free Report) had its price target raised by Cormark from C$25.00 to C$30.00 in a research note released on Wednesday,BayStreet.CA reports.
Several other equities research analysts have also issued reports on the stock. CIBC raised their price target on shares of Extendicare from C$18.00 to C$22.00 in a research note on Thursday, November 13th. BMO Capital Markets increased their price objective on Extendicare from C$15.00 to C$21.00 in a report on Monday, November 17th. Cibc World Mkts upgraded Extendicare to a “strong-buy” rating in a research note on Monday, September 22nd. National Bankshares upped their price target on Extendicare from C$21.50 to C$24.50 and gave the company an “outperform” rating in a research report on Wednesday. Finally, TD Securities increased their price target on Extendicare from C$15.00 to C$19.00 in a research note on Thursday, November 13th. Three investment analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Extendicare currently has a consensus rating of “Buy” and a consensus price target of C$23.86.
View Our Latest Research Report on Extendicare
Extendicare Stock Performance
Extendicare Dividend Announcement
The business also recently declared a monthly dividend, which was paid on Monday, November 17th. Stockholders of record on Monday, November 17th were given a $0.042 dividend. The ex-dividend date was Friday, October 31st. This represents a c) annualized dividend and a dividend yield of 2.3%. Extendicare’s payout ratio is 46.60%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Articles
- Five stocks we like better than Extendicare
- What Are Growth Stocks and Investing in Them
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- What is a SEC Filing?
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
